21-38422958-T-G

Position:

• chr21-38422958-T-G

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_182918.4(ERG):​c.388+452A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.955 in 152,184 control chromosomes in the GnomAD database, including 69,388 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.95 (69388 hom., cov: 31)
• Consequence: ERG NM_182918.4 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: -0.335

Genes affected

ERG (HGNC:3446): (ETS transcription factor ERG) This gene encodes a member of the erythroblast transformation-specific (ETS) family of transcriptions factors. All members of this family are key regulators of embryonic development, cell proliferation, differentiation, angiogenesis, inflammation, and apoptosis. The protein encoded by this gene is mainly expressed in the nucleus. It contains an ETS DNA-binding domain and a PNT (pointed) domain which is implicated in the self-association of chimeric oncoproteins. This protein is required for platelet adhesion to the subendothelium, inducing vascular cell remodeling. It also regulates hematopoesis, and the differentiation and maturation of megakaryocytic cells. This gene is involved in chromosomal translocations, resulting in different fusion gene products, such as TMPSSR2-ERG and NDRG1-ERG in prostate cancer, EWS-ERG in Ewing's sarcoma and FUS-ERG in acute myeloid leukemia. More than two dozens of transcript variants generated from combinatorial usage of three alternative promoters and multiple alternative splicing events have been reported, but the full-length nature of many of these variants has not been determined. [provided by RefSeq, Apr 2014]

ACMG classification

Verdict is Benign. Variant got -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.98).
• BA1: GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.98 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
ERG	NM_182918.4	c.388+452A>C		intron_variant		ENST00000288319.12	NP_891548.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
ERG	ENST00000288319.12	c.388+452A>C		intron_variant		1	NM_182918.4	ENSP00000288319	P4

Frequencies

GnomAD3 genomes AF: 0.954 AC: 145137 AN: 152066 Hom.: 69322 Cov.: 31

Gnomad AFR AF: 0.988

Gnomad AMI AF: 0.984

Gnomad AMR AF: 0.937

Gnomad ASJ AF: 0.929

Gnomad EAS AF: 0.988

Gnomad SAS AF: 0.961

Gnomad FIN AF: 0.956

Gnomad MID AF: 0.930

Gnomad NFE AF: 0.936

Gnomad OTH AF: 0.940

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.955 AC: 145262 AN: 152184 Hom.: 69388 Cov.: 31 AF XY: 0.955 AC XY: 71079 AN XY: 74390

Gnomad4 AFR AF: 0.988

Gnomad4 AMR AF: 0.937

Gnomad4 ASJ AF: 0.929

Gnomad4 EAS AF: 0.988

Gnomad4 SAS AF: 0.962

Gnomad4 FIN AF: 0.956

Gnomad4 NFE AF: 0.936

Gnomad4 OTH AF: 0.941

Alfa AF: 0.937 Hom.: 82565

Bravo AF: 0.954

Asia WGS AF: 0.971 AC: 3379 AN: 3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.98
CADD	Benign	1.5
DANN	Benign	0.43

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs1571704; hg19: chr21-39794880;